The Enterprise Value as of December 2025 (TTM) for ZIOPHARM Oncology, Inc. (ZIOP) is 7.59M

According to ZIOPHARM Oncology, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 7.59M. This represents a change of -99.42% compared to the average of 1.32B of the last 4 quarters.

ZIOPHARM Oncology, Inc. (ZIOP) Historical Enterprise Value (quarterly & annually)

How has ZIOP Enterprise Value performed in the past?

The mean historical Enterprise Value of ZIOPHARM Oncology, Inc. over the last ten years is 367.66M. The current 7.59M Enterprise Value has changed 106.49% with respect to the historical average. Over the past ten years (40 quarters), ZIOP's Enterprise Value was at its highest in in the September 2025 quarter at 5.26B. The Enterprise Value was at its lowest in in the December 2024 quarter at 1.97M.

ZIOPHARM Oncology, Inc. (ZIOP) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of ZIOPHARM Oncology, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

ZIOPHARM Oncology, Inc. (ZIOP) Average Enterprise Value

How has ZIOP Enterprise Value performed in the past?

The current Enterprise Value of ZIOPHARM Oncology, Inc. (ZIOP) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

ZIOPHARM Oncology, Inc. (ZIOP) Enterprise Value vs. Peers

How is ZIOP’s Enterprise Value compared to its peers?

ZIOPHARM Oncology, Inc.’s Enterprise Value is less than Spectrum Pharmaceuticals, Inc. (199.44M), less than CARGO Therapeutics, Inc. Common Stock (109.02M), less than LakeShore Biopharma Co., Ltd (624.71M), greater than Vaccitech plc (-34608760.00), less than Zevra Therapeutics, Inc. (484.06M), less than Acelyrin, Inc. (176.86M), less than Theseus Pharmaceuticals, Inc. (90.87M), less than LENZ Therapeutics, Inc. (469.74M), less than Inozyme Pharma, Inc. (279.36M), less than Cytocom, Inc. (224.44M),

Build a custom stock screener for ZIOPHARM Oncology, Inc. (ZIOP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ZIOPHARM Oncology, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ZIOPHARM Oncology, Inc. (ZIOP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ZIOPHARM Oncology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.